Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Hu: Unmasking Conserved Epitopes |
| Strategy: | Combo: Protein & vector vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Mouse |
| Stage: | Assays Completed |
| Study Start Date: | 2014-07-07 |
| Study Made Public: | 2016-02-16 |
Title
Cytoplasmic tail modifications in HIV-1/89.6 Env can improve the neutralizing antibody response
Description
CAVD 458 is a preclinical mouse study to evaluate cytoplasmic tail modifications that increase Env surface expression in the context of a vaccinia virus/Env prime-Env protein boost regimen.
Sign in to see full information about this study and to download study data.
Products
Alum v-NY-SIV gag/pol Env gp120 (89.6 N7) v-NY-Env gp160 (89.6 N7) v-NY-Env gp160 (89.6 N7) HM v-NY-Env gp160 (89.6 N7) FMIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.